Gestational diabetes is blood sugar elevation during pregnancy and exposes women to the risk for development of type 2 diabetes mellitus in later years of life. The LEP rs7799039 (2548G/A ) polymorphis m in the 5´ region of the LEP gene was reported not only to be associated with overweight but also to have a strong influence on leptin gene expression and adipose tissue secretion. The aim of this study is to evaluate the distribution of LEP rs7799039 (2548G/A ) polymorphis m and its plasma level in patients with gestational Diabetes Mellitus. This s tudy was carried out on160 subjects divided into 2 groups; 80 patients with GDM (g roup I) and 80 healthy subjects served as controls (group II). All studied subjects were submitted to full h istory taking, general clin ical examination and laboratory investigations including fasting and 2 hour post prandial blood glucose, total cholesterol (TC),triglycerides (TG), HDLc, LDLc, g lycated hemoglobin (HbA1c), p lasma leptin, fasting serum insulin, HOMA -IR and Genotyping of LEP rs
Introduction
Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy (1) and is defined as any degree of glucose intolerance with the first recognition during pregnancy. This includes undiagnosed diabetes mellitus detected for the first time during pregnancy(2).Gestational Diabetes Mellitus and gestational dysregulation of blood glucose levels expose the women affected to a higher risk for subsequent development of type 2 diabetes mellitus and cardiovascular disease later in their lives(3,4).
The adverse outcomes associated with GDM for both the mother and the offspring are diverse.
They include short-term complications such as macrosomia, neonatal hypoglycemia, preeclampsia, as well as long-term risk of type 2 diabetes mellitus, obesity and cardiovascular diseases both in the mother and in their offspring(5). The risk of GDM women is increased by advanced maternal age, ancestral disparities, obesity, and a family history of diabetes; however, the exact etiology is unknown due to limited knowledge of genetic factors (6).
Leptin affects the balance of cytokines in the feto-placental unit (7), and therefore the pregnancy outcome (8,9). Also, leptin synthesized in the placenta acts through binding to leptin receptors, which are expressed in the trophoblast (10, 11).
Secretion of leptin influence body weight, positively associated with percentage body fat, suggesting that leptin levels is mediating adiposity signals to the brain (12). Excessive production of leptin is a consequence of resistance to its effect on target organs (13), and increased levels are associated with high BMI and insulin resistance in type 2 diabetes patients (T2DM) (14).
One polymorphism has been associated with increased leptin production and plasma secretion from adipocytes(18).
Subjects and methods

Subjects:
This case-control study included (160) subjects: 
Sample collection and assay
Prior to the collection of samples, written consent (approved by the Committee of Human Rights in
Research at Menoufia University) were obtained from all studied cases and control subjects.
After 12 hours overnight fasting, 12 ml of venous blood were withdrawn from every subject by sterile vein-puncture and divided into three tubes; respectively. P-value < 0.05 was considered statistically significant.
Results
The study was conducted on a total number of 160 subjects divided into two groups as follows; There were significant statistical differences found between the three genotypes regarding these parameters with the highest plasma leptin in AA genotype as shown in (figure 5 and Table   3 )..Multivariate logistic regression for risk of GDM showed that the most common risk factor is plasma leptin OR; 32.1(6.1-169.5), followed by 
Discussion
Gestational diabetes mellitus (GDM), one of the most common pregnancy complications, is defined as the first recognition of glucose intolerance during pregnancy. Adverse pregnancy outcomes of GDM impact on both mothers and their offspring during and after pregnancy (31) . Insulin resistance is an important characteristic of both Type II Diabetes and GDM. Several adipokines including leptin, visfatin, adiponectin and resistin are reported to be involved in development of insulin res istance (32).The aim of this work was to evaluate LEP-2548 G/A single nucleotide polymorphism [SNP] at position -2548 G/A and plasma leptin level as risk factors for GDM.
In our current study, There was a statistically significant difference between the two studied groups regarding age,serum FBG,HBA1C,SBP, DBP,2HPP, TC,TG ,LDLc, HDLc fasting insulin, HOMA-IR, baby WT, plasma leptin ,family history of DM and pre pregnancy BMI. This result was in agree with Mei Yang et al.,2016 (33) who reported that the pregnant women with GDM had a higher age, pre-pregnant body mass index (BMI), systolic blood pressure, diastolic blood pressure and fasting blood glucose (P <0.001).
Furthermore, the women with impaired fasting glucose (IFG) had significantly higher fasting p lasma leptin levels than normal glucose tolerance (NGT) group.(34)also showed that GDM is associated with insulin resistance and adverse maternal health outcomes such as gestational hypertension and pre -eclampsia, and neonatal outcomes including hyperinsulinaemia, macrosomia, shoulder dystocia, later life risk of obesity and T2DM. Khalid S. et al., (35) reported that the diabetic patients had higher BMI, serum triglyceride and HbA1c values when compared to non-diabetic subjects. Whereas, had lower HDL level. This study revealed that obesity and dyslipidemia were high among diabetic patients. In our study plasma leptin level was significantly higher in GDM than control group .concerning this It has been reported that the levels of leptin were increased (36, 37, 38), decreased (39) or unchanged(40) in GDM. Noureldeen, et al., (41) reported that plasma leptin levels did not significantly change at 2 nd trimester but decrease at 3 rd trimester among GDM women (42) .In our current study there was significant difference regarding the Leprs7799039 genotype distribution between the two studied groups, with increased frequency of the AA and AG genotypes and A allele in the patient(GDM) group and increased GG genotype and G allele frequency in the control group.
The result also showed that the AA genotype of Leprs7799039(G/A) increases the risk of GDM by 8.3-fold and AG genotype increases the risk by 4.1-fold, while the A allele increases the risk by 4.2-fold,with highest plasma leptin in AA genotype this result was in agree with Julie Anna et al., (42) who reported that the significantly higher risk for gestational diabetes mellitus was observed in the presence of an allele (AA and AG genotypes) against carriers of GG genotype (OR=2.84, 95%CI 1.14-7.07, p=0.02). There is a significant risk of diabetes mellitus associated to A allele (OR=1.79, 95%CI 1.02-3.14, p=0.03). In our study; Multivariate logistic regression for risk of GDM showed that the most common risk factor is plasma leptin OR; 32.1 (6.1-169. 
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